Performance of a smell identification test versus the Mini-Mental Status Exam for the detection of dementia and cognitive impairment among persons with cognitive concerns in primary care
J Alzheimers Dis. 2025 May 21:13872877251345083. doi: 10.1177/13872877251345083. Online ahead of print.
ABSTRACT
BackgroundOdor identification deficits predict Alzheimer’s disease (AD) in epidemiological studies.ObjectiveTo compare the accuracy of a short odor identification test with a short cognitive screening test for the detection of dementia and cognitive impairment in elderly persons with cognitive concerns.MethodsThis was a cross-sectional study of 600 participants 65 years and older, without known mild cognitive impairment (MCI) or dementia, with cognitive concerns, attending primary care practices in New York City. The odor identification test was the Brief Smell Identification Test (BSIT). The comparator test was the Mini Mental Status Exam II (MMSE). Cognitive diagnoses were made using the National Alzheimer’s Coordinating Center Uniform Data set (NACC-UDS) version 3 forms with slight modifications. Test performance was compared using Receiver Operating Characteristic analyses.ResultsThe mean age was 72.65 ± 6.31 years, 73.3% were female, 63.3% were Hispanic, 13.5% non-Hispanic Black, and 20.8% non-Hispanic White; 23.5% were classified as normal cognition, 27.7% as cognitive impairment-not mild cognitive impairment (MCI), 31.2% as amnestic MCI, 5.7% as non-amnestic MCI, and 12% as dementia. The MMSE was superior to the BSIT in detecting dementia and any cognitive impairment. Combining abnormal scores in the BSIT (≤8) to MMSE (≤24) improved the MMSE’s specificity and positive predictive value (PPV) in detecting cognitive impairment.ConclusionsThe MMSE was superior to the BSIT in detecting dementia and cognitive impairment in primary care but using both tests improved specificity and PPV for identifying persons with subjective complaints needing further cognitive and biomarker evaluation.
Asian J Psychiatr. 2025 May 16;109:104534. doi: 10.1016/j.ajp.2025.104534. Online ahead of print.ABSTRACTOBJECTIVE: Optimizing antipsychotic dosage is crucial for patients to resume functioning without increased risk...
J Clin Ethics. 2025 Summer;36(2):196-200. doi: 10.1086/734769.ABSTRACTAbstractTransplant psychiatry is a rapidly growing field all across the nation. There are no clear biopsychosocial criteria for transplantation,...
J Dev Behav Pediatr. 2025 May 9. doi: 10.1097/DBP.0000000000001377. Online ahead of print.ABSTRACTOBJECTIVE: Although the recommended first-line treatment for attention-deficit hyperactivity disorder (ADHD) is medication,...
JMIR Res Protoc. 2025 May 21;14:e72585. doi: 10.2196/72585.ABSTRACTBACKGROUND: Walking difficulties are a common and costly problem. However, disability associated with the decline in walking ability...
JMIR Res Protoc. 2025 May 21;14:e65044. doi: 10.2196/65044.ABSTRACTBACKGROUND: Patients with post-COVID-19 condition (PCC) experience persistent, long-term health consequences following SARS-CoV-2 infection, including fatigue, hyperventilation, cognitive...
JMIR Aging. 2025 May 21;8:e66212. doi: 10.2196/66212.ABSTRACTBACKGROUND: Persons living with dementia and their caregivers experience frequent emotional health challenges. Across the illness spectrum, engaging in...
